Steven L. Chang

Dr. Steven Lee Chang is a urologic oncologist affiliated with Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts. He holds the position of Associate Professor of Surgery at Harvard Medical School (HMS). Dr. Chang earned his medical degree from Columbia University, College of Physicians & Surgeons, and completed his Urology residency training and Urologic Oncology fellowship at Stanford University Medical Center. His academic pursuits are marked by being an NIH-funded health services researcher in urologic oncology applying mathematical modeling and large database analytical techniques to optimize the perioperative management of urologic cancers, with a focus on minimizing their economic impact on the healthcare system. Additionally, Dr. Chang serves on the governing board of the Dana-Farber/Harvard Cancer Center (DF/HCC) Kidney Cancer SPORE. He actively engages in clinical trials and translational research within the DF/HCC Research Consortium.

14th August 2025

Time	Session

18:30 21:00	Industry Symposium 1 【Minimal Invasive Surgery Medical Foundation】 Single Port(SP) Urological Surgery Experience Sharing Opening Jeff S. ChuehTaiwan Speaker How to start SP application in Urology? Jeff S. ChuehTaiwan Moderator Ryoichi Shiroki Japan Moderator Steven L. ChangUnited States Speaker What are patient selection criterion for SP in early phase? Jeff S. ChuehTaiwan Moderator Ryoichi Shiroki Japan Moderator John DavisUnited States Speaker Pivoting your procedure to broader range New approach and application with SP Jeff S. ChuehTaiwan Moderator Ryoichi Shiroki Japan Moderator Simone CrivellaroUnited States Speaker Things need to know Tips and Tricks from setup to surgery Jeff S. ChuehTaiwan Moderator Ryoichi Shiroki Japan Moderator Ketan BadaniUnited States Speaker TBD Q&A and discussion (Panel discussion) TICC - 1F 101B

Time

Session

18:30

21:00

Industry Symposium 1 【Minimal Invasive Surgery Medical Foundation】

Single Port(SP) Urological Surgery Experience Sharing

Opening

Jeff S. ChuehTaiwan Speaker
How to start SP application in Urology?

Jeff S. ChuehTaiwan Moderator

Ryoichi Shiroki Japan Moderator

Steven L. ChangUnited States Speaker
What are patient selection criterion for SP in early phase?

Jeff S. ChuehTaiwan Moderator

Ryoichi Shiroki Japan Moderator

John DavisUnited States Speaker
Pivoting your procedure to broader range New approach and application with SP

Jeff S. ChuehTaiwan Moderator

Ryoichi Shiroki Japan Moderator

Simone CrivellaroUnited States Speaker
Things need to know Tips and Tricks from setup to surgery

Jeff S. ChuehTaiwan Moderator

Ryoichi Shiroki Japan Moderator

Ketan BadaniUnited States Speaker
TBD
Q&A and discussion (Panel discussion)

TICC - 1F 101B

15th August 2025

Time	Session

13:30 15:00	Oncology 1 Renal Cell Carcinoma Renal Cell Carcinoma Chi-Ping HuangTaiwan Moderator Duc Minh PhamVietnam Moderator RCC and IVC Thrombectomy Siros JitpraphaiThailand Speaker Cytoreductive Nephrectomy in the Era of Immune Therapy Surya Prakash VaddiIndia Speaker Robotic Partial Nephrectomy: Making Things Easier Brian Sze-ho HoHong Kong, China Speaker How to Make the Best Decision with Systemic Therapy Sequence in Respective of Genetic Analysis Po-Hung LinTaiwan Speaker Comparison of Remal Function between Radiofrequency Ablation versus Robot Assisted Laparoscopic Patial Nephrectomy for Small Renal Mass in Elderly Patients Seong Il SeoKorea (Republic of) Speaker The Progression Landscape of Diagnostic and Treatment Options for Kidney Cancer Steven L. ChangUnited States Speaker TICC - 2F 201BC

Time

Session

13:30

15:00

Oncology 1

Renal Cell Carcinoma

Renal Cell Carcinoma

Chi-Ping HuangTaiwan Moderator

Duc Minh PhamVietnam Moderator
RCC and IVC Thrombectomy

Siros JitpraphaiThailand Speaker
Cytoreductive Nephrectomy in the Era of Immune Therapy

Surya Prakash VaddiIndia Speaker
Robotic Partial Nephrectomy: Making Things Easier

Brian Sze-ho HoHong Kong, China Speaker
How to Make the Best Decision with Systemic Therapy Sequence in Respective of Genetic Analysis

Po-Hung LinTaiwan Speaker
Comparison of Remal Function between Radiofrequency Ablation versus Robot Assisted Laparoscopic Patial Nephrectomy for Small Renal Mass in Elderly Patients

Seong Il SeoKorea (Republic of) Speaker
The Progression Landscape of Diagnostic and Treatment Options for Kidney Cancer

Steven L. ChangUnited States Speaker

TICC - 2F 201BC

16th August 2025

Time	Session

10:30 12:00	Robotic Robotic Surgery Robotic Surgery Jian-Ri LiTaiwan Moderator KoonHo RhaKorea (Republic of) Moderator Pai-Fu WangTaiwan Moderator How to Standardize Training by AI-Learning from The Best Practice of Urological Robotic Surgery Ketan BadaniUnited States Speaker Discussion Complex Robotic Assisted Surgery for Urinary Fistula Repair Allen W. ChiuTaiwan Speaker Discussion Pros and Cons in the daVinci SP System Applications in Urological Surgeries Steven L. ChangUnited States Speaker Discussion TICC - 2F 201DE
13:30 15:00	BPH/MIST Crossfire (2): > 100g BPH/MIST Crossfire (2): > 100g Jeff S. ChuehTaiwan Moderator Jeremy TeohHong Kong, China Moderator Mitsui TakahikoJapan Commenter Chi-Shin TsengTaiwan Commenter Chih-Chieh LinTaiwan Facilitator Shih-Ting ChiuTaiwan Facilitator Giorgio BozziniItaly Speaker Steven L. ChangUnited States Speaker Simone CrivellaroUnited States Speaker Dean EltermanCanada Speaker Christopher NetschGermany Speaker TICC - 1F 102